IRONWOOD PHARMACEUTICALS, INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
IRONWOOD PHARMACEUTICALS, INC. (IRWD) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $471.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $471.00K.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $265.00K.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $654.00K, a 78.02% decline year-over-year.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $312.00K.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$1.98M, a 150.15% decline from fiscal 2024.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $3.95M.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$3.03M.
- IRONWOOD PHARMACEUTICALS, INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2018 was $79.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-06-30 | $471.00K 10-Q · filed 2026-08-06 | $736.00K 10-Q · filed 2026-08-06 | $1.39M derived: sum of 3 quarters · filed 2026-08-06 | $1.70M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $265.00K 10-Q · filed 2026-05-07 | $919.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.23M derived: sum of 3 quarters · filed 2026-05-07 | -$1.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $654.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $966.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.35M derived: sum of 3 quarters · filed 2026-08-06 | -$1.98M 10-K · filed 2026-02-26 |
| 2025-09-30 | $312.00K 10-Q · filed 2025-11-10 | -$2.01M derived: sum of 2 quarters · filed 2026-08-06 | -$2.64M 10-Q · filed 2025-11-10 | $338.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$2.32M 10-Q · filed 2026-08-06 | -$2.95M 10-Q · filed 2026-08-06 | $26.00K derived: sum of 3 quarters · filed 2026-08-06 | -$1.56M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$629.00K 10-Q · filed 2026-05-07 | $2.35M derived: sum of 2 quarters · filed 2026-05-07 | $764.00K derived: sum of 3 quarters · filed 2026-05-07 | $1.22M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $2.98M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $1.39M derived: sum of 2 quarters · filed 2026-02-26 | $1.84M derived: sum of 3 quarters · filed 2026-02-26 | $3.95M 10-K · filed 2026-02-26 |
| 2024-09-30 | -$1.58M 10-Q · filed 2025-11-10 | -$1.13M derived: sum of 2 quarters · filed 2025-11-10 | $979.00K 10-Q · filed 2025-11-10 | -$1.28M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $452.00K 10-Q · filed 2025-08-11 | $2.56M 10-Q · filed 2025-08-11 | $301.00K derived: sum of 3 quarters · filed 2025-08-11 | -$470.00K derived: sum of 4 quarters · filed 2025-08-11 |
| 2024-03-31 | $2.11M 10-Q · filed 2025-05-12 | -$151.00K derived: sum of 2 quarters · filed 2025-05-12 | -$922.00K derived: sum of 3 quarters · filed 2025-05-12 | |
| 2023-12-31 | -$2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$3.03M derived: sum of 2 quarters · filed 2025-03-31 | -$3.03M 10-K · filed 2025-03-31 | |
| 2023-09-30 | -$771.00K 10-Q · filed 2024-11-07 | -$771.00K 10-Q · filed 2024-11-07 | ||
| 2018-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-17 | $44.00K derived: sum of 2 quarters · filed 2021-02-17 | $91.00K derived: sum of 3 quarters · filed 2021-02-17 | $79.00K 10-K · filed 2021-02-17 |
| 2018-09-30 | $35.00K 10-Q · filed 2019-10-31 | $82.00K derived: sum of 2 quarters · filed 2019-10-31 | $70.00K 10-Q · filed 2019-10-31 | -$3.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-06-30 | $47.00K 10-Q · filed 2019-07-30 | $35.00K 10-Q · filed 2019-07-30 | -$38.00K derived: sum of 3 quarters · filed 2020-02-13 | -$20.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2018-03-31 | -$12.00K 10-Q · filed 2019-05-02 | -$85.00K derived: sum of 2 quarters · filed 2020-02-13 | -$67.00K derived: sum of 3 quarters · filed 2020-02-13 | -$50.00K derived: sum of 4 quarters · filed 2020-02-13 |
| 2017-12-31 | -$73.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-13 | -$55.00K derived: sum of 2 quarters · filed 2020-02-13 | -$38.00K derived: sum of 3 quarters · filed 2020-02-13 | -$72.00K 10-K · filed 2020-02-13 |
| 2017-09-30 | $18.00K 10-Q · filed 2018-11-06 | $35.00K derived: sum of 2 quarters · filed 2018-11-06 | $1.00K 10-Q · filed 2018-11-06 | -$67.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-06-30 | $17.00K 10-Q · filed 2018-08-06 | -$17.00K 10-Q · filed 2018-08-06 | -$85.00K derived: sum of 3 quarters · filed 2019-02-25 | -$63.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2017-03-31 | -$34.00K 10-Q · filed 2018-05-04 | -$102.00K derived: sum of 2 quarters · filed 2019-02-25 | -$80.00K derived: sum of 3 quarters · filed 2019-02-25 | -$70.00K derived: sum of 4 quarters · filed 2019-02-25 |
| 2016-12-31 | -$68.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-25 | -$46.00K derived: sum of 2 quarters · filed 2019-02-25 | -$36.00K derived: sum of 3 quarters · filed 2019-02-25 | $79.00K 10-K · filed 2019-02-25 |
| 2016-09-30 | $22.00K 10-Q · filed 2017-11-02 | $32.00K derived: sum of 2 quarters · filed 2017-11-02 | $147.00K 10-Q · filed 2017-11-02 | $13.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-06-30 | $10.00K 10-Q · filed 2017-08-03 | $125.00K 10-Q · filed 2017-08-03 | -$9.00K derived: sum of 3 quarters · filed 2018-02-22 | $17.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2016-03-31 | $115.00K 10-Q · filed 2017-05-08 | -$19.00K derived: sum of 2 quarters · filed 2018-02-22 | $7.00K derived: sum of 3 quarters · filed 2018-02-22 | $26.00K derived: sum of 4 quarters · filed 2018-02-22 |
| 2015-12-31 | -$134.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-22 | -$108.00K derived: sum of 2 quarters · filed 2018-02-22 | -$89.00K derived: sum of 3 quarters · filed 2018-02-22 | -$67.00K 10-K · filed 2018-02-22 |
| 2015-09-30 | $26.00K 10-Q · filed 2016-11-07 | $45.00K derived: sum of 2 quarters · filed 2016-11-07 | $67.00K 10-Q · filed 2016-11-07 | $23.00K derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-06-30 | $19.00K 10-Q · filed 2016-08-08 | $41.00K 10-Q · filed 2016-08-08 | -$3.00K derived: sum of 3 quarters · filed 2017-02-22 | $19.00K derived: sum of 4 quarters · filed 2017-02-22 |
| 2015-03-31 | $22.00K 10-Q · filed 2016-05-10 | -$22.00K derived: sum of 2 quarters · filed 2017-02-22 | $0.00 derived: sum of 3 quarters · filed 2017-02-22 | $15.00K derived: sum of 4 quarters · filed 2017-02-22 |
| 2014-12-31 | -$44.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$22.00K derived: sum of 2 quarters · filed 2017-02-22 | -$7.00K derived: sum of 3 quarters · filed 2017-02-22 | -$21.00K 10-K · filed 2017-02-22 |
| 2014-09-30 | $22.00K 10-Q · filed 2015-11-05 | $37.00K derived: sum of 2 quarters · filed 2015-11-05 | $23.00K 10-Q · filed 2015-11-05 | $6.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | $15.00K 10-Q · filed 2015-08-07 | $1.00K 10-Q · filed 2015-08-07 | -$16.00K derived: sum of 3 quarters · filed 2016-02-19 | $4.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$14.00K 10-Q · filed 2015-05-06 | -$31.00K derived: sum of 2 quarters · filed 2016-02-19 | -$11.00K derived: sum of 3 quarters · filed 2016-02-19 | -$24.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $3.00K derived: sum of 2 quarters · filed 2016-02-19 | -$10.00K derived: sum of 3 quarters · filed 2016-02-19 | -$3.00K 10-K · filed 2016-02-19 |
| 2013-09-30 | $20.00K 10-Q · filed 2014-11-05 | $7.00K derived: sum of 2 quarters · filed 2014-11-05 | $14.00K 10-Q · filed 2014-11-05 | $12.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-06-30 | -$13.00K 10-Q · filed 2014-08-05 | -$6.00K 10-Q · filed 2014-08-05 | -$8.00K derived: sum of 3 quarters · filed 2015-02-18 | $8.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2013-03-31 | $7.00K 10-Q · filed 2014-04-29 | $5.00K derived: sum of 2 quarters · filed 2015-02-18 | $21.00K derived: sum of 3 quarters · filed 2015-02-18 | $9.00K derived: sum of 4 quarters · filed 2015-02-18 |
| 2012-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-18 | $14.00K derived: sum of 2 quarters · filed 2015-02-18 | $2.00K derived: sum of 3 quarters · filed 2015-02-18 | -$1.00K 10-K · filed 2015-02-18 |
| 2012-09-30 | $16.00K 10-Q · filed 2013-10-28 | $4.00K derived: sum of 2 quarters · filed 2013-10-28 | $1.00K 10-Q · filed 2013-10-28 | |
| 2012-06-30 | -$12.00K 10-Q · filed 2013-08-08 | -$15.00K 10-Q · filed 2013-08-08 | ||
| 2012-03-31 | -$3.00K 10-Q · filed 2013-04-23 | |||
| 2011-12-31 | $5.00K 10-K · filed 2014-02-07 | |||
| 2011-03-31 | $51.00K 10-Q · filed 2012-05-10 | |||
| 2010-12-31 | $1.00K 10-K · filed 2013-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |